Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Efoora to test rapid HIV test in the US:

This article was originally published in Clinica

Executive Summary

Efoora has gained permission from the US FDA to begin clinical trials of its rapid HIV screening test. The HIV Rapid test will be assessed at a number of US centres and data generated from the studies will be used to support a premarket approval application for the product. The test, which is sensitive to HIV antibodies indicative of infection, can produce a result in 20 minutes, says the Buffalo Grove, Illinois firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel